Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Accelerate Diagnostics stock | 8.71

Own Accelerate Diagnostics stock in just a few minutes.

Posted

Fact checked

Accelerate Diagnostics, Inc is a diagnostics & research business based in the US. Accelerate Diagnostics shares (AXDX) are listed on the NASDAQ and all prices are listed in US Dollars. Accelerate Diagnostics employs 275 staff and has a trailing 12-month revenue of around USD$10.2 million.

How to buy shares in Accelerate Diagnostics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Accelerate Diagnostics. Find the stock by name or ticker symbol: AXDX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Accelerate Diagnostics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$8.71, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Accelerate Diagnostics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Accelerate Diagnostics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Accelerate Diagnostics's share price?

Since the stock market crash in March caused by coronavirus, Accelerate Diagnostics's share price has had significant negative movement.

Its last market close was USD$8.71, which is 46.00% down on its pre-crash value of USD$16.13 and 92.27% up on the lowest point reached during the March crash when the shares fell as low as USD$4.53.

If you had bought USD$1,000 worth of Accelerate Diagnostics shares at the start of February 2020, those shares would have been worth USD$346.61 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$509.10.

Accelerate Diagnostics share price

Use our graph to track the performance of AXDX stocks over time.

Accelerate Diagnostics shares at a glance

Information last updated 2020-10-20.
Latest market close USD$8.71
52-week range USD$4.53 - USD$19.11
50-day moving average USD$11.0917
200-day moving average USD$11.8807
Wall St. target price USD$19
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.599

Buy Accelerate Diagnostics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Accelerate Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Accelerate Diagnostics price performance over time

Historical closes compared with the close of $8.71 from 2020-11-16

1 week (2020-11-20) 4.44%
1 month (2020-10-30) -7.54%
3 months (2020-08-28) -27.78%
6 months (2020-05-29) 4.31%
1 year (2019-11-29) -41.70%
2 years (2018-11-29) -37.61%
3 years (2017-11-29) -68.89%
5 years (2015-11-27) -49.45%

Accelerate Diagnostics financials

Revenue TTM USD$10.2 million
Gross profit TTM USD$4.4 million
Return on assets TTM -31.71%
Return on equity TTM -837.84%
Profit margin 0%
Book value $0.187
Market capitalisation USD$656 million

TTM: trailing 12 months

Shorting Accelerate Diagnostics shares

There are currently 15.7 million Accelerate Diagnostics shares held short by investors – that's known as Accelerate Diagnostics's "short interest". This figure is 5.1% up from 14.9 million last month.

There are a few different ways that this level of interest in shorting Accelerate Diagnostics shares can be evaluated.

Accelerate Diagnostics's "short interest ratio" (SIR)

Accelerate Diagnostics's "short interest ratio" (SIR) is the quantity of Accelerate Diagnostics shares currently shorted divided by the average quantity of Accelerate Diagnostics shares traded daily (recently around 284158.6475707). Accelerate Diagnostics's SIR currently stands at 55.16. In other words for every 100,000 Accelerate Diagnostics shares traded daily on the market, roughly 55160 shares are currently held short.

However Accelerate Diagnostics's short interest can also be evaluated against the total number of Accelerate Diagnostics shares, or, against the total number of tradable Accelerate Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accelerate Diagnostics's short interest could be expressed as 0.28% of the outstanding shares (for every 100,000 Accelerate Diagnostics shares in existence, roughly 280 shares are currently held short) or 0.4933% of the tradable shares (for every 100,000 tradable Accelerate Diagnostics shares, roughly 493 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Accelerate Diagnostics.

Find out more about how you can short Accelerate Diagnostics stock.

Accelerate Diagnostics share dividends

We're not expecting Accelerate Diagnostics to pay a dividend over the next 12 months.

Accelerate Diagnostics share price volatility

Over the last 12 months, Accelerate Diagnostics's shares have ranged in value from as little as $4.53 up to $19.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accelerate Diagnostics's is 2.5367. This would suggest that Accelerate Diagnostics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Accelerate Diagnostics overview

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site